文章摘要
陈理丹,姚沛,段华新.合并大血管侵犯的原发性肝细胞癌病人外放射治疗进展[J].安徽医药,2024,28(1):16-21.
合并大血管侵犯的原发性肝细胞癌病人外放射治疗进展
Progress of external radiation therapy for patients with hepatocellular carcinoma complicated with macrovascular invasion
  
DOI:10.3969/j.issn.1009-6469.2024.01.004
中文关键词: 癌,肝细胞  放射疗法,调强适形  质子疗法  门静脉瘤栓  肝静脉瘤栓
英文关键词: Carcinoma, hepatocellular  Radiotherapy, intensity-modulated  Proton therapy  Portal vein tumor thrombus  Hepatic vein tumor thrombus
基金项目:
作者单位E-mail
陈理丹 湖南师范大学附属第一医院、湖南省人民医院肿瘤科湖南长沙 410000  
姚沛 湖南师范大学附属第一医院、湖南省人民医院肿瘤科湖南长沙 410000  
段华新 湖南师范大学附属第一医院、湖南省人民医院肿瘤科湖南长沙 410000 317102912@qq.com 
摘要点击次数: 359
全文下载次数: 89
中文摘要:
      原发性肝细胞癌(HCC)病人确诊时常发现合并大血管侵犯(MVI)如门静脉瘤栓(PVTT)、肝静脉瘤栓(HVTT)及下腔静脉瘤栓(IVCTT)等。而大血管侵犯常预示着病人预后欠佳。目前可供选择的,治疗方式多样,但缺少对伴有大血管侵犯的 HCC治疗的专家共识。随着外放射治疗技术的发展,外放射治疗已成为 HCC合并大血管侵犯的重要治疗手段之一。因此,现针对外放射治疗在合并大血管侵犯的肝细胞癌中的应用情况进行总结,以期为合并大血管侵犯的肝癌病人提供更多的治疗选择。
英文摘要:
      Patients with primary hepatocellular carcinoma (HCC) often have macrovascular invasion (MVI), such as portal vein tumorthrombus (PVTT), hepatic vein tumor thrombus (HVTT), and inferior vena cava tumor thrombus (IVCTT). MVI often predicts a poorprognosis for patients. Various treatment options are currently available, but there is a lack of expert consensus on the management ofHCC with MVI. With the development of external radiotherapy technology, external radiotherapy has become an important treatmentmethod for HCC complicated with MVI. Therefore, the application of external radiation therapy in HCC with MVI is summarized, in or-der to provide more treatment options for HCC patients with MVI.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮